Glucose transporter 2 mediates the hypoglycemia-induced increase in cerebral blood flow

• Published in: Journal of cerebral blood flow and metabolism Vol. 39; no. 9; pp. 1725 - 1736
• Main Authors: Lei, Hongxia, Preitner, Frédéric, Labouèbe, Gwenaël, Gruetter, Rolf, Thorens, Bernard
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.09.2019
• Subjects: Animals; Blood Glucose - metabolism; Brain - blood supply; Brain - metabolism; Cerebrovascular Circulation; Glucose Transporter Type 2 - metabolism; Hypoglycemia - blood; Hypoglycemia - metabolism; Male; Mice, Inbred C57BL; Original; cerebral blood flow; Glut2; optogenetic; hypoglycemia; glut2 brain cells
• ISSN: 0271-678X; 1559-7016; 1559-7016
• DOI: 10.1177/0271678X18766743

Glucose transporter 2 (Glut2)-positive cells are sparsely distributed in brain and play an important role in the stimulation of glucagon secretion in response to hypoglycemia. We aimed to determine if Glut2-positive cells can influence another response to hypoglycemia, i.e. increased cerebral blood flow (CBF). CBF of adult male mice devoid of Glut2, either globally (ripglut1:glut2−/−) or in the nervous system only (NG2KO), and their respective controls were studied under basal glycemia and insulin-induced hypoglycemia using quantitative perfusion magnetic resonance imaging at 9.4 T. The effect on CBF of optogenetic activation of hypoglycemia responsive Glut2-positive neurons of the paraventricular thalamic area was measured in mice expressing channelrhodopsin2 under the control of the Glut2 promoter. We found that in both ripglut1:glut2−/− mice and NG2KO mice, CBF in basal conditions was higher than in their respective controls and not further activated by hypoglycemia, as measured in the hippocampus, hypothalamus and whole brain. Conversely, optogenetic activation of Glut2-positive cells in the paraventricular thalamic nucleus induced a local increase in CBF similar to that induced by hypoglycemia. Thus, Glut2 expression in the nervous system is required for the control of CBF in response to changes in blood glucose concentrations.